Skip to main content
Download PDF

Sexually dimorphic effects of prenatal alcohol exposure on the murine skeleton

Biology of Sex Differences volume 15, Article number: 51 (2024) Cite this article

Abstract

Background

Prenatal alcohol exposure (PAE) can result in lifelong disabilities known as foetal alcohol spectrum disorder (FASD) and is associated with childhood growth deficiencies and increased bone fracture risk. However, the effects of PAE on the adult skeleton remain unclear and any potential sexual dimorphism is undetermined. Therefore, we utilised a murine model to examine sex differences with PAE on in vitro bone formation, and in the juvenile and adult skeleton.

Methods

Pregnant C57BL/6J female mice received 5% ethanol in their drinking water during gestation. Primary calvarial osteoblasts were isolated from neonatal offspring and mineralised bone nodule formation and gene expression assessed. Skeletal phenotyping of 4- and 12-week-old male and female offspring was conducted by micro-computed tomography (µCT), 3-point bending, growth plate analyses, and histology.

Results

Osteoblasts from male and female PAE mice displayed reduced bone formation, compared to control (≤ 30%). Vegfa, Vegfb, Bmp6, Tgfbr1, Flt1 and Ahsg were downregulated in PAE male osteoblasts only, whilst Ahsg was upregulated in PAE females. In 12-week-old mice, µCT analysis revealed a sex and exposure interaction across several trabecular bone parameters. PAE was detrimental to the trabecular compartment in male mice compared to control, yet PAE females were unaffected. Both male and female mice had significant reductions in cortical parameters with PAE. Whilst male mice were negatively affected along the tibial length, females were only distally affected. Posterior cortical porosity was increased in PAE females only. Mechanical testing revealed PAE males had significantly reduced bone stiffness compared to controls; maximum load and yield were reduced in both sexes. PAE had no effect on total body weight or tibial bone length in either sex. However, total growth plate width in male PAE mice compared to control was reduced, whilst female PAE mice were unaffected. 4-week-old mice did not display the altered skeletal phenotype with PAE observed in 12-week-old animals.

Conclusions

Evidence herein suggests, for the first time, that PAE exerts divergent sex effects on the skeleton, possibly influenced by underlying sex-specific transcriptional mechanisms of osteoblasts. Establishing these sex differences will support future policies and clinical management of FASD.

Plain English summary

Prenatal alcohol exposure (PAE) can lead to a set of lifelong cognitive, behavioural, and physical disabilities known as foetal alcohol spectrum disorder (FASD). FASD is a significant burden on healthcare, justice and education systems, which is set to worsen with rising alcohol consumption rates. FASD children have an increased risk of long bone fracture and adolescents are smaller in stature. However, sex differences and the long-term effects of PAE on the skeleton have not been investigated and was the aim of this study. Using a mouse model of PAE, we examined the function and gene expression of bone-forming cells (osteoblasts). We then analysed the skeletons of male and female mice at 12-weeks-old (adult) and 4-weeks-old (juvenile). PAE reduced osteoblast bone formation in both sexes, compared to control. Differential gene expression was predominantly observed in PAE males and largely involved genes related to blood vessel formation. High resolution x-ray imaging (micro-CT) revealed PAE had a detrimental effect on the inner trabecular bone component in 12-week-old male mice only. Analysis of the outer cortical bone revealed that whilst both male and female PAE mice were negatively affected, anatomical variations were observed. Mechanical testing also revealed differences in bone strength in PAE mice, compared to control. Interestingly, 4-week-old mice did not possess these sex differences observed in our PAE model at 12 weeks of age. Our data suggest PAE has detrimental and yet sex-dependent effects on the skeleton. Establishing these sex differences will support future policies and clinical management of FASD.

Highlights

Primary calvarial osteoblasts isolated from male and female PAE mice displayed reduced mineralised bone nodule formation and differential gene expression compared to control.

PAE had a detrimental effect on trabecular bone parameters in 12-week-old male mice only.

PAE leads to spatial variation in cortical bone parameters and geometry, with male mice negatively affected along the tibial length and female mice only affected at the distal end.

Mechanical testing revealed PAE male mice had significantly reduced bone stiffness compared to controls; PAE in both sexes reduced maximum load and yield.

4-week-old mice did not display the altered skeletal phenotype with PAE observed in 12-week-old animals.

Background

There is increasing evidence to suggest that the intrauterine environment influences lifelong skeletal health [1,2,3]. Prenatal alcohol exposure (PAE) can lead to lifelong disabilities known as foetal alcohol spectrum disorder (FASD). FASD is associated with over 400 comorbidities and adverse outcomes in later life [4, 5]. It is characterised by a variety of cognitive and physical impairments, notably its effects on brain development, facial dysmorphology, central nervous system (CNS) malformations, and has since been associated with learning difficulties [6]. It is a leading cause of developmental disability, affecting approximately 1–10% of children in the USA and Europe, and resulting in a significant burden on healthcare, social, justice and education systems [7,8,9]. Recent analysis of the Avon Longitudinal Study of Parents and Children estimated that the screen prevalence in this UK population-based cohort was 17% [10], whilst global prevalence of children born with foetal alcohol syndrome (FAS), the most severe form of FASD, is estimated to be > 100,000 per year [11].

Whilst the effects of PAE on craniofacial differences are well documented [12,13,14,15], studies investigating the clinical effects on the rest of the skeleton are limited. Early small-scale studies and case reports highlighted skeletal malformations including digital abnormalities (e.g. clinodactyly), carpal fusion, radioulnar synostosis, cervical spine abnormalities, and skeletal dysplasia [16,17,18]. Since then, growth deficiencies have become a hallmark of FASD and are observed in children exposed to alcohol in utero, at any point during pregnancy [13, 19, 20]. Additionally, there is increasing evidence that adolescents with FASD are shorter, have a reduced head circumference and a delayed mean bone age [19, 21,22,23]. Similarly, PAE is associated with an increased risk of a long bone fracture in childhood [24], and with reduced bone mineral density (BMD) and lean tissue mass in adolescents [23].

In animal models, there is further evidence that PAE results in skeletal irregularities. Skeletal malformations such as fused or abnormal ribs, delayed hindlimb ossification, forelimb anomalies and digit defects have been observed in the offspring of mice given ethanol via intraperitoneal injection or as part of their diet [25, 26]. Foetal growth, bone development and percent ossification are also disrupted in rat foetuses during high and moderate ethanol exposure [27,28,29], alongside disturbances to calcium homeostasis [27, 30]. Similarly, studies in sheep show high dose alcohol exposure during pregnancy reduces foetal bone length and strength [31,32,33]. Further, alongside its effects on bone, PAE also alters cartilage development as it disrupts the organisational zones of the growth plate, decreasing the length of the resting zone and increasing the length of the hypertrophic zones of chondrocytes [34].

Whilst these data suggest a detrimental effect of PAE on bone development, the long-term effects on the adult skeleton have not been fully investigated. Similarly, whilst sex differences in human FASD populations have been observed across various systems and clinical outcomes, including neurodevelopment, cognitive performance, endocrine disorders, facial dysmorphology, pre- and post-partum mortality, body composition and metabolic abnormalities [35,36,37], any potential sexual dimorphism associated with bone architecture and composition is unclear [23]. As evidence suggests that diagnosis and disease presentation of these patients can alter between males and females, establishing these sex differences will support future policies and clinical management [35]. In addition, addressing sex bias in skeletal research, particularly in preclinical models, is necessary for effective translation into a clinical setting [38]. Therefore, in this study we utilised a murine model to examine potential sex differences with PAE on in vitro bone formation and in the juvenile and skeletally mature skeleton.

Methods

Animals

Pregnant C57Bl/6J females received 5% ethanol in their drinking water during gestation from day 0. Fluid intake between control (water-only) and alcohol-exposed females was unchanged. All mice utilised in these studies were kept in controlled conditions at the University of Brighton. All tissue isolation and experimental procedures were performed in accordance with the UK Animals (Scientific Procedures) Act of 1986 and regulations set by the UK Home Office and local institutional guidelines. No differences in litter size or sex ratio were observed between control and PAE breeding pairs (Suppl. Table 1). Tissues were collected from male and female mice at 4- and 12- weeks of age, following euthanasia by cervical dislocation. For 12-week animals: n = 8 control males, n = 11 PAE males, n = 9 control females, n = 8 PAE females. For 4-week animals: n = 5 control males, n = 9 PAE males, n = 10 control females, n = 7 PAE females. Analyses were conducted blindly to minimise the effects of subjective bias. Animal studies were conducted and reported in line with the ARRIVE guidelines.

Primary osteoblast cultures

Osteoblasts were isolated from the calvariae of male and female 3–5-day old mice from control and PAE dams by trypsin/collagenase digestion, as previously described [39, 40]. Timed matings were performed to ensure cells were isolated from control and PAE offspring at the same time. Cells were expanded in Alpha Minimum Essential Medium supplemented with 10% foetal bovine serum (FBS), 100 U/ml penicillin, and 100 µg/ml streptomycin (mixture abbreviated to αMEM). Following plating in 6-well plates at 105 cells/well and 12-well plates at 5 × 104 cells/well, osteoblasts were cultured for up to 21 days in αMEM supplemented with 2mM β-glycerophosphate and 50 µg/ml ascorbic acid, with half medium changes every 3 days. Time points in osteoblast cultures were: differentiating (Day 7), mature (Day 14), and mature, bone forming (Day 21). All experiments were performed on cells that were isolated, expanded and plated; the cells were not passaged at any stage.

Assessment of mineralisation

Experiments were terminated after 21 days by fixing the cells in 2.5% glutaraldehyde for 5 min. Plates were imaged at 800dpi using a flat-bed scanner and the total area of bone nodules was quantified by image analysis, as described previously [40]. Alizarin red (1% w/v) stained images were obtained, as previously described [41].

Quantitative polymerase chain reaction (qPCR) and PCR array

RNA was isolated and purified from primary osteoblast cultures at day 7 and 14 of culture using the Qiagen RNeasy mini kit, according to the manufacturer’s instructions. For the PCR array, 2µg of RNA from day 7 cultures was reverse transcribed using a Qiagen RT2 First Strand Kit, according to manufacturer’s instructions. Gene expression changes associated with osteogenesis were assessed using an RT2 Profiler™ PCR Array (PAMM-026Z, Qiagen). A fold regulation threshold of 2 was used to determine up- or down- regulation of each gene in male and female PAE mice compared to control and data is presented as log2 fold change, relative to the control. Subsequently, qPCR analysis of key genes identified in the PCR array was conducted at days 7 and 14 of culture. RNA (2µg) was reverse transcribed using a Qiagen QuantiTect RT kit, according to the manufacturer’s instructions. The PCR was performed using cDNA (50ng) and a Brilliant II sybr green mastermix (Agilent). Both the PCR array and qPCR were run on an Agilent AriaMx PCR machine. Gene expression data for the qPCR were normalized to β-actin and analysed using the ΔΔCt method [42]. Primer sequences can be found in Supplementary Table 2.

MicroCT (µCT) analysis

Scans of the left tibia were performed with an 1172 X-Ray microtomograph (Skyscan). High-resolution scans with voxel size of 5 μm were acquired (50 kV, 200µA, 0.5 mm aluminium filter, 0.6° rotation angle). The projection images were reconstructed using NRecon software (Skyscan). Each dataset was rotated in DataViewer (Skyskan) to ensure similar orientation and alignment for analysis. Segmentation of the datasets was performed in CTAn software (Skyscan) to exclude the fibula. 3D analysis of the trabecular bone was performed using a volume of interest of 5% of the total bone length. This region extended distally from the bottom of the growth plate where the primary spongiosa is no longer visible towards the diaphysis. A binarised image with a minimum threshold set to 85 was used across all datasets and 3D measurements taken in CTAn. BMD measurements were calibrated using the same measurements with appropriate phantoms. Cortical bone was analysed using a 2D whole-bone approach to visualise changes across the entire tibia [43]. To ensure trabecular bone was not included in the analysis, the proximal and distal 10% of the tibial length were excluded. Slice by slice measurements were created in CTAn using binarised images with a minimum threshold set to 80. 3D images for cortical and trabecular regions were created using Avizo software (ThermoFisher Scientific).

Cortical porosity

Using the tibial µCT scans, 200 slices starting at the tibiofibular junction were imported into FIJI ImageJ. First, thresholds were determined to create binary images, followed by ‘Keep Largest Region’ to isolate the tibia. Using ‘Moment of Inertia’, unaligned scans were aligned so each region would fall in a quadrant [44]. Anterior, medial, lateral, and posterior regions were expected to show spatial differences [45] and therefore extracted by halving the canvas size. A filled mask was created and the marrow cavity subtracted, resulting in a cortical tissue mask. Intracortical canals were extracted by subtracting the binary tibial image from this mask, with no extraction of osteocyte lacunae due to low resolution. With BoneJ’s ‘Particle Analyser’, cortical porosity in % (canal volume normalised for cortical tissue volume) was assessed [46]. 3D reconstructions were created in ORS Dragonfly using ‘Contour Mesh’ for visualisation.

Three-point bending

Left femurs were cleaned of soft tissue and frozen in distilled water at -20 °C. Three‐point bending was carried out on thawed bones using a Lloyd LRX5 materials testing machine (Lloyd Instruments) fitted with a 100 N load cell. The span was fixed at 10 mm and bones loaded with a crosshead speed of 1 mm/min until failure, as previously described [47]. Load extension curves were generated to identify maximum load. Stiffness and yield were calculated from the slope of the linear region of the load extension curve using polynomial fit.

Histological analysis

Right tibiae were fixed for 24 h in 4% paraformaldehyde before being decalcified in 10% ethylenediaminetetraacetic acid (EDTA) for 21 days at 4oC, wax-embedded and 6 μm coronal sections cut. Slides were stained with H&E using standard procedures. For TRAP staining 70 mg napthol AS-TR phosphate (Sigma) was dissolved in 250 µl N-N dimethyl formamide (Sigma) and added to 50 ml 0.2 M sodium acetate buffer pH 5.2. 115 mg sodium tartrate dihydrate (Sigma) and 70 mg fast red salt TR (Sigma) was dissolved into this solution and slides were incubated at 37oC for 2 h. Sections were counterstained in Meyer’s haematoxylin (Sigma), washed in distilled water and mounted in aqueous mounting medium (Vector Labs) [48].

Growth plate zone and bridge analysis

The width of the growth plate proliferating and hypertrophic zones, as well as the total growth plate width, were measured at 10 different points along the length of the growth plate based on established cell morphology. Measurements were conducted in 6 μm coronal sections from the middle region of the tibia in similar location of four individual animals per experimental group, using a light microscope and ImageJ software. Growth plate bridge analysis was conducted using a 3D µCT quantification method as previously described [49]. Briefly, µCT scans of the tibiae were segmented using a region-growing algorithm within the Avizo software. The central points of all bony bridges were identified and projected on the tibial joint surface to allow spatial distribution.

Statistical analysis

Analyses were performed using GraphPad Prism software (version 10.1.2). For in vitro analyses, results are presented as bar graphs with points from individual experiments (n = 4 biological replicates); containing 3–6 technical replicates. For ex vivo skeletal phenotyping, data are presented as bar graphs with points for individual animals. Normal distribution of data was assessed using the Shapiro-Wilk normality test. For comparison between control and PAE datasets in both males and females, a two-way ANOVA followed by Tukey’s post hoc analysis was used to test for significance. qPCR data was analysed using an unpaired, two-tailed t test. Results are presented as the mean ± standard error of the mean (SEM).

For the cortical bone analysis, R software (version 4.2.2) was used to generate line graphs and perform statistical analyses. Normal distribution of data was assessed using the Shapiro-Wilk normality test. For comparison between control and PAE datasets in both males and females, a two-way ANOVA followed by Tukey’s post hoc analysis was used to test for significance. Lines represent mean, with shading representing ± SEM. Colour heatmaps display the statistical significance at matched locations along the graph showing the PAE effect (in males and females) and the sex effect (in controls and PAE). Red = p < 0.001, green = p < 0.01, yellow = p < 0.05, blue = p > 0.05 (not significant).

Results

Utilising a murine model of PAE, the aim of this study was to examine the role PAE has on in vitro bone formation and skeletally phenotype mice at 4- and 12-weeks of age. Herein, osteoblasts derived from control and PAE neonates of both sexes were used to investigate the effects of PAE on bone cell function. Tibias and femurs from both male and female mice were used to investigate growth plate, trabecular and cortical bone architecture, alongside mechanical testing. Figure 1 shows a schematic of the study protocol.

Fig. 1
figure 1

Schematic of experimental design. Pregnant dams were exposed to 5% ethanol in their drinking water (prenatal alcohol exposure (PAE)) or normal drinking water. Offspring were sacrificed at postnatal (p) days 3–5 for primary osteoblast cultures, or 4- and 12-weeks of age for skeletal phenotyping. Created with Biorender.com

Full size image

PAE reduces in vitro bone formation in males and females but results in sex-dependent differences in osteoblast gene expression

To understand whether PAE alters osteoblast differentiation and function, primary osteoblasts derived from calvarial neonates were used as an effective model of in vitro bone formation [39]. Mineralised nodule formation in cells derived from both PAE males and females was reduced by ≤ 30%, compared to control cells (p < 0.001; Fig. 2A & B). An osteogenesis PCR array performed at day 7 of culture, during the differentiation stage of primary osteoblasts, highlighted several genes that were differentially expressed between male and female cultures. qPCR was performed to confirm the results observed in the array at day 7, and to also assess their expression during osteoblast maturation (day 14). The PCR array revealed that Bglap (osteocalcin), Csf2 and Gli1 were upregulated in control females compared to control males, whilst Bmp6, Col14a1 and Flt1 (VEGFR) were downregulated (Table 1). Compared to PAE males, female PAE osteoblasts only showed an increase in Ahsg (Fetuin-A). PAE also differentially affected osteoblast gene expression compared to control within each sex. In the PCR array, upregulation of Bglap and Ahsg was observed in both PAE males and females compared to control (Table 1). However, this was not consistent with subsequent qPCR analysis which only showed an increase in Ahsg expression during the maturation phase in PAE females compared to control (p < 0.01; Fig. 2C&D). Whilst the array revealed downregulation of Vegfa in PAE osteoblasts from both sexes, significant downregulation was only confirmed in PAE males via qPCR (p < 0.05; Fig. 2C). At day 14, Vegfa remained downregulated in PAE males compared to control (p < 0.05; Fig. 2C). Bmp6, Tgfbr1 and Flt1 were also downregulated in PAE male mice compared to control (Table 1), an effect that was confirmed by qPCR (p < 0.05; Fig. 2C). However, the decrease in Vegfb observed in the array only showed a trend towards downregulation that did not reach significance when the qPCR was performed (Fig. 2C). In females, qPCR analysis revealed no differences between control and PAE osteoblasts at day 7 (Fig. 2D).

Fig. 2
figure 2

PAE reduces in vitro bone formation and results in sex-dependent differences in osteoblast gene expression. (A) Mineralised bone nodule area of primary calvarial osteoblasts from PAE male and female mice as a percentage of the control cultures. (B) Representative whole-well scans and light microscopy images of mineralised nodules. (C) RT-qPCR of key genes identified by RT2-profiler analysis (Vegfa, Vegfb, Flt1, Tgfbr1, Bmp6, Ahsg, and Bglap) on days 7 and 14 of culture from osteoblasts derived from male control and PAE, and (D) female control and PAE mice (data normalised to β-actin). Data are presented as mean ± SEM with points showing individual experiments. *= p < 0.05, **= p < 0.01, ***= p < 0.001. Scale bars: whole well = 0.5 cm, microscopy = 200 μm

Full size image
Table 1 Osteogenesis PCR array of control and PAE primary osteoblasts from male and female mice. Data is presented as log2 fold change, relative to males or relative to the control
Full size table

PAE has a detrimental effect on trabecular bone parameters in male mice, whilst female mice are protected

We next sought to examine whether the alterations in bone formation and osteoblast commitment in cells from neonatal PAE mice had lasting effects on the adult skeleton. In 12-week-old mice, µCT analysis revealed a sex and exposure interaction across a number of trabecular parameters in the tibia (Fig. 3A-I). Males and females were significantly different from each other in both control and PAE animals (p < 0.05). However, in male mice compared to control, PAE was detrimental to the trabecular compartment. Specifically, PAE significantly reduced many of these parameters including tissue volume (p < 0.0001; Fig. 3A), bone volume (p < 0.0001; Fig. 3B), bone volume/tissue volume (p < 0.05; Fig. 3C), bone surface (p < 0.0001; Fig. 3D) and intersection surface (p < 0.0001; Fig. 3E). The structure and architecture of the trabeculae was also altered in PAE male mice (Fig. 3F-I). Trabecular number (p = 0.051; Fig. 3F), fractal dimension (p < 0.05; Fig. 3G) and connectivity density (p < 0.001; Fig. 3H) were decreased, whilst trabecular pattern factor (p < 0.05; Fig. 3I) was increased, indicating a more disconnected and less complex trabecular compartment. However, female mice were unaffected by PAE, with no significant differences observed in any of the trabecular bone parameters examined (Fig. 3A-I). Representative 3D-reconstructed images of the trabecular compartment highlight these differences between males and females (Fig. 3J). Additional parameters and parameters that were unaffected by PAE in either sex, such as trabecular thickness, trabecular separation and bone mineral density are shown in Supplementary Fig. 1.

Fig. 3
figure 3

PAE has a detrimental effect on the trabecular microarchitecture in male mice. µCT analysis of the tibial (A) tissue volume, (B) bone volume, (C) bone volume to tissue volume ratio (BV/TV), (D) bone surface, (E) intersection surface, (F) trabecular number (Tb.N), (G) fractal dimension, (H) connectivity density (Conn.Dn) and (I) trabecular pattern factor (Tb.Pf) in male and female PAE and control mice. (J) Representative 3D-reconstructed images of the trabecular region in control and PAE mice. Data are presented as mean ± SEM with points showing individual animals. *= p < 0.05, ***= p < 0.001, ****= p < 0.0001

Full size image

PAE leads to spatial variation in cortical bone parameters, geometry and biomechanical properties in both males and females

To assess the effect of PAE along the full length of the tibia, 2D whole bone analysis was performed (Fig. 4). In both control and PAE mice, females showed a reduction in each parameter compared to males along almost the entirety of the bone (p < 0.05; Fig. 4A-F). However, in both sexes compared to control, PAE negatively affected cortical parameters including tissue area (p < 0.05; Fig. 4A), tissue perimeter (p < 0.05; Fig. 4B), and cortical bone area (p < 0.05; Fig. 4C). Whilst PAE males compared to control males were affected along the entire length of the tibia, female PAE mice only showed differences to control at the distal end (Fig. 4A–C). In addition, PAE also similarly altered parameters associated with cortical bone shape in these mice, including predicted resistance to torsion (J; p < 0.05; Fig. 4D), maximum (Imax; p < 0.05; Fig. 4E) and minimum (Imin; p < 0.05; Fig. 4F) moments of inertia. Again, these alterations were found along the length of the tibia in PAE males relative to control males, whereas PAE females were only affected more distally (Fig. 4D-F). Interestingly, across several parameters, a specific area around the tibiofibular junction (60%) was differentially affected between males and females, whereby PAE females showed reductions in these parameters compared to controls (p < 0.01), whilst PAE males were unaffected.

Fig. 4
figure 4

PAE leads to spatial variation in changes in tibial cortical parameters and geometry. Measurement and statistical analysis heat map for (A) tissue area (T. Ar), (B) tissue perimeter (T.Pm), (C) Bone area (B.Ar), (D) resistance to torsion (J), (E) maximum second moments of inertia (Imax) and (F) minimum second moments of inertia (Imin) in male and female PAE and control mice. Line graphs represent mean ± SEM for male control (black), male PAE (orange), female control (green) and female PAE (blue) mice. Graphical heat map summarises statistical differences at specific matched locations along the tibial length (10–90%), for the PAE effect in females (Ctl-PAE F) and males (Ctl-PAE M), and the sex effect in control (F-M Ctl) and PAE (F-M PAE) groups. Red = p < 0.001, green = p < 0.01, yellow = p < 0.05, blue = p > 0.05 (not significant)

Full size image

We next sought to examine whether the cortical changes observed were associated with any changes in cortical porosity, using the tibiofibular junction as an anatomical landmark (Fig. 5A). Whilst there were no differences in total cross-sectional cortical porosity between control and PAE mice in both sexes (Fig. 5B), regional analysis revealed changes in the posterior region of the tibia in female PAE mice only. In both sexes, the posterior region contained greater porosity compared to the anterior, lateral and medial regions (p < 0.05; Fig. 5C). However, PAE females had greater porosity in this region compared to control females (p < 0.001) and to PAE males (p < 0.01). PAE males were unaffected compared to control and no sex differences were observed in control animals (Fig. 5C).

Fig. 5
figure 5

PAE females display increased cortical porosity in the posterior region of the tibiofibular junction. (A) 3D renderings of intracortical canals (red) from male and female control and PAE mice. (B) Percentage cross-sectional cortical porosity and (C) percentage regional cortical porosity in anterior, medial, lateral and posterior regions. Data are presented as mean ± SEM with points showing individual animals. # denotes significant difference from anterior region within experimental group; ¤ denotes significant difference from medial region within experimental group; † denotes significant difference from lateral region within experimental group; * denotes significant difference between specific regions in different experimental groups. One symbol = p < 0.05, two symbols = p < 0.001, three symbols = p < 0.001

Full size image

Three-point bending was performed to investigate whether the observed changes in bone microarchitecture and geometry with PAE influence bone material properties. Sex differences were observed in the control and PAE groups with maximum load (p < 0.05), whereas stiffness was lower in control females compared to males (p < 0.01; Table 2). Whilst no sex and exposure interaction was evident, PAE male and female mice showed a significantly decreased maximum load, and yield compared to control animals (p < 0.05). However, a sex and exposure interaction (p = 0.0489) was observed for stiffness and PAE male mice had significantly reduced bone stiffness compared to male controls (p < 0.001; Table 2).

Table 2 Three-point bending analysis of 12-week and 4-week-old control and PAE mice, in males and females. Data represented as mean ± SEM for n > 5/experimental group. a = control male vs. female, b = PAE male vs. female, c = male control vs. PAE, d = female control vs. PAE. 1 symbol denotes p < 0.05, 2 symbols denote p < 0.01, 3 symbols denote p < 0.001
Full size table

PAE decreases growth plate width in males, despite no effects on bone length or growth plate bridging in either sex

At 12 weeks of age, females weighed less and had shorter tibias than males in both control and PAE groups (p < 0.05; Table 3).

Table 3 Weight and bone lengths of 12-week and 4-week control and PAE mice, in males and females. Tibial bone lengths were measured using µCT. Data represented as mean ± SEM for n > 5/experimental group. a = control male vs. female, b = PAE male vs. female. 1 symbol denotes p < 0.05, 2 symbols denote p < 0.01, 3 symbols denote p < 0.001
Full size table

Despite this, we observed no changes in total growth plate width with sex in either control or PAE groups (Fig. 6A & B). In both sexes, PAE had no effect on total body weight, or on tibial bone length, and no sex and exposure interaction was observed (Table 3). However, total growth plate width in male PAE mice compared to control was reduced (p < 0.05), whilst female PAE mice compared to control were unaffected (Fig. 6A & B). Sex differences in the proliferative and hypertrophic zones of the growth plate were not observed in the control group, whereas an increase in the hypertrophic zone was seen in females compared to males in the PAE group only (p < 0.05; Fig. 6C & D). This was coupled with trends towards a reduction in the width of the proliferative zone, observed in both males and females with PAE compared to control (Fig. 6C), and in the hypertrophic zone (Fig. 6D). No apparent differences in TRAP labelling for osteoclasts were observed between males and females of either group or between control and PAE mice of either sex (Fig. 6A). Growth plate bridging assessment in these animals revealed a reduction in the number of bridges in female PAE mice compared to male PAE (p < 0.001), whilst sex differences in areal density were observed in both control and PAE groups (p < 0.01; Fig. 6E-G). No significant differences were observed between control and PAE mice of either sex, but a significant sex and exposure interaction (p = 0.0121) suggests there may be an effect on growth plate fusion (Fig. 6E-G).

Fig. 6
figure 6

PAE decreases growth plate width in male mice. (A) TRAP and haemotoxylin and eosin-stained sections of male and female PAE and control 12-week-old mice. (B) Total growth plate zone width, (C) Proliferative zone width, and (D) Hypertrophic zone width, of male and female control and PAE mice. Ten measurements per section were obtained along the length of the tibial growth plate in the middle region of the knee joint. (E) Location and areal densities of bridges across the growth plate projected on the tibial joint surface in male and female control and PAE mice. (F) Number of bridges. (G) Areal density (d) of bridges defined as the number of bridges per 256 mm x 256 mm window. Data are presented as mean ± SEM with points showing individual animals. *= p < 0.05, * p < 0.01, ***= p < 0.001

Full size image

Juvenile 4-week-old mice do not display the altered skeletal phenotype with PAE that are observed in skeletally mature male and female mice

To assess whether the changes in the skeletons of PAE male and female mice are seen throughout development, we next investigated juvenile mice that are not yet skeletally mature. Whilst tibial lengths were unchanged between males and females, females weighed less than males in both the control and the PAE groups (p < 0.05; Table 3). Body weight and bone length were unchanged in PAE mice compared to control in either sex (Table 3). Asides from tissue volume (Fig. 7A), similarly to 12-week animals, males and females differed across several trabecular parameters in both control and PAE groups (p < 0.05; Fig. 7B-H). Interestingly, however, no sex and exposure interaction was evident and the detrimental effects of PAE to the trabecular bone microarchitecture observed in male 12-week-old animals were not observed at 4-weeks of age (Fig. 7A-H, Suppl. Figure 2). Similarly, no or limited effects on cortical bone geometry were observed in either sex with PAE compared to control, or in control males compared to females (Fig. 7I-N). However, sex differences in the PAE groups were observed, with PAE females displaying a reduction in cortical parameters along the tibial length compared to PAE males (p < 0.05; Fig. 7I-N). This effect was also evident in bone strength measurements as no changes in biomechanical properties were observed in control mice compared to PAE in either sex, or in males compared to females in the control group (Table 2). Load and stiffness were reduced in females compared to males in the PAE group (p < 0.05), whilst yield was unchanged. There was no sex and exposure interaction for any of these parameters.

Fig. 7
figure 7

Juvenile mice do not display the altered skeletal phenotype that are observed in skeletally mature mice. µCT analysis of the trabecular compartment, including (A) tissue volume, (B) bone volume, (C) bone volume to tissue volume ratio (BV/TV), (D) bone surface, and (E) trabecular number (Tb.N), (F) trabecular pattern factor (Tb.Pf), (G) fractal dimension, and (H) connectivity density (Conn.Dn) in control and PAE males and females. Data are presented as mean ± SEM with points showing individual animals. *= p < 0.05, ***= p < 0.001, ****= p < 0.0001. Measurement and statistical analysis heat map for (I) tissue area (T. Ar), (J) tissue perimeter (T.Pm), (K) Bone area (B.Ar), (L) resistance to torsion (J), (M) maximum second moments of inertia (Imax) and (N) minimum second moments of inertia (Imin) in male and female PAE and control mice. Line graphs represent mean ± SEM for male control (black), male PAE (orange), female control (green) and female PAE (blue) mice. Graphical heat map summarises statistical differences at specific matched locations along the tibial length (10–90%) for the PAE effect in females (Ctl-PAE F) and males (Ctl-PAE M), and the sex effect in control (F-M Ctl) and PAE (F-M PAE) groups. Red = p < 0.001, green = p < 0.01, yellow = p < 0.05, blue = p > 0.05 (not significant)

Full size image

Discussion

PAE has previously been shown to alter foetal skeletal development in animal models, however the effects on the mature skeleton are unclear. Herein, we investigated the role of PAE on osteoblast function and gene expression in cells from male and female mice. Primary calvarial osteoblast function revealed reductions in mineralised nodule formation and sex-dependent changes on gene expression between control and PAE mice. To assess whether these alterations had any dimorphic effects later in life we conducted skeletal phenotyping of a murine model of PAE in both sexes, examining bones from skeletally mature and juvenile mice in the skeleton. In 12-week-old mice (skeletally mature), we observed clear differences between (i) sexes of each group and (ii) PAE and control animals within each sex in the growth plate, trabecular and cortical regions of the bone. However, how these differences presented were dependent on the sex. Whilst PAE male mice were affected along the entire length of the bone compared to control, PAE females only appeared to be affected in the cortical bone at the most distal end of the tibia and at the tibiofibular junction. Interestingly, 4-week-old juvenile mice did not possess these sex differences. This together suggests that the detrimental effects of PAE on the skeleton are sexually dimorphic (Fig. 8).

Fig. 8
figure 8

Sexually dimorphic effects of PAE on the skeleton. PAE osteoblasts from males and females produce less bone nodules than normal cells yet gene expression is differentially affected. This has lasting effects on the skeleton as PAE in 12-week-old male mice detrimentally alters the trabecular and cortical regions of the bone, bone mechanical properties and the growth plate. However, PAE female mice are protected in the growth plate and trabecular regions, but show detrimental effects only in the distal region of the tibia and at the tibiofibular junction

Full size image

The concept that the in-utero environment can alter the disease risk of a foetus later in life, termed as foetal programming, is widely accepted. The Barker hypothesis, in which foetuses that have adapted to limited nutrition during gestation are ‘programmed’ to be more at risk to cardiovascular diseases and diabetes in later life, gave an early indication that the prenatal environment can have lasting effects [50]. Disturbances to maternal diet and vitamin intake, smoking or substance abuse during pregnancy and the teratogenic effects of some chemicals and medications have all been shown to disturb foetal development [51,52,53]. Indeed, exposure to mycotoxins, environmental pollutants, medicinal products such as retinoic acid and methotrexate all result in skeletal abnormalities in rodent foetuses [54,55,56]. Further, limb defects have been noted in children prenatally exposed to cocaine and the deformities caused by thalidomide are well documented [57, 58]. Interestingly, long-term osteopenic effects of prenatal cocaine exposure have been observed in skeletally mature male rats at 32-weeks of age [59], whilst 5-month-old mice exposed in utero to the DNA methylation inhibitor, 5-aza-2-deoxycytidine, had negative alterations to their femoral microarchitecture e.g. bone volume fraction and trabecular number [60]. However, the long-term effects of compounds that do not have such severe or profound effects on the skeletal tissue has not been fully investigated.

Limiting alcohol consumption during pregnancy is now well accepted due to its negative impact on brain development, yet global prevalence of FASD remains high [11]. In human cohorts, the lasting effects of ethanol on the developing foetus, particularly in skeletal tissues, remain relatively unknown. This is in part due to the presence of confounding factors, including inaccurate self-reporting, polymorphisms in alcohol metabolism, and coupling of alcohol with other insults e.g. smoking or illicit drug abuse [10, 61]. Animal models have the benefit of removing these confounding factors and controlling variables that human studies are limited by, alongside demonstrating dose-response relationships that can be employed to target different levels of PAE [61, 62]. Therefore, utilising preclinical animal models to investigate the sole effects of PAE (particularly low to moderate doses) on the skeleton is essential.

In this study, murine dams were given free access to drinking water containing 5% ethanol. No difference in water consumption was observed between control (water-only) and PAE-treated mothers, thus our model of PAE is more akin to long term, continual alcohol exposure that accumulates over time. A previous study demonstrated that the alcohol intake of breeding females in this murine model of 5% ethanol was ~ 11 g/kg/day, proportional to a human daily ethanol intake of approximately 100 g, the equivalent of one bottle of wine [63]. Whilst consideration needs to be given to the sampling time as rodents primarily drink during the dark phase, leading to variability in blood alcohol concentrations, thus ultimately suggests that 11 g/kg/day average-model used herein results in low-dose exposure [63]. This contrasts with other studies that look at the effects of binge drinking, single exposure or short-term exposure [26, 32]. For example, a single dose intraperitoneal injection of ethanol at gestational day 7 has been shown to increase prenatal mortality in mice and skeletal deformities, yet low-level exposure via ethanol inhalation over several days did not result in any abnormalities [26].

Interestingly, studies using animal models tend to show that male animals are more detrimentally affected by PAE than females [35, 63]. Indeed, individuals with FASD experience sex-related differences in clinical presentation, with males presenting significantly more neurodevelopmental impairment and females with more endocrine disorders [35]. Further, males with FASD exhibit larger volume reductions in brain structure than females [64]. Sex-specific differences during development are thought to lead to these long-term impacts. Whilst ethanol can cross the placental barrier and therefore directly risk the foetus during development, the foetal liver itself is not mature enough to metabolise ethanol directly [65]. However, the maternal environment, such as the levels of circulating cytokines and alterations in immune and microRNA (miRNA) profiles, are modulated by foetal sex and are thought to play a role in these differences. Similarly, placental sex differences are observed leading to altered endocrine factor release to both the maternal and foetal environment. Ethanol is known to alter the cytokine milieu [66] and PAE has also been shown to affect circulating maternal cytokines and miRNAs [67,68,69], as well as release of placental endocrine factors [70]. Modulation of this maternal and foetal environment contributes to sex-specific differences throughout life, thus suggesting that ethanol-sensitive immune and epigenetic factors during development could result in sex disparities in clinical outcomes. However, human studies investigating FASD often do not report sex-specific differences either due to insufficient sample sizes or limited efforts to stratify for sex [71]. This is also true of studies specifically investigating skeletal effects of FASD. In their study on bone composition alterations in FASD children, Young and colleagues highlight the challenges surrounding combining male and female data and suggests that sex-specific effects may exist in this population [23]. This is to our knowledge, the first report of sex differences in the skeleton in pre-clinical models and therefore warrants further investigation of individuals with FASD to inform on stratified treatment.

Our initial analysis focused on calvarial osteoblasts isolated from neonates as this represents an effective model of in vitro bone formation [40]. We observed a clear reduction in bone nodule formation, regardless of sex with PAE, and our PCR array and subsequent qPCR analysis highlighted several genes that were differentially affected by PAE compared to controls in both males and females. Upregulation of Ahsg mRNA expression was observed in PAE females during the osteoblast maturation stage, whilst downregulation was observed in PAE males during the differentiation stage. Fetuin-A stabilises the formation of calciprotein particles that are required for excess clearance of mineral precursors [72]. Given the reduction in osteoblast mineralisation observed with PAE, increases in inhibitors of mineralisation would be expected. As Fetuin-A is predominantly produced in osteocytes, rather than osteoblasts [73], its effects on osteoblast-mediated bone formation may be limited and only play a minor role in PAE-mediated mineralisation changes. Additionally, genes associated with mineralisation inhibition (e.g. Opg) or induction (e.g. Alpl) were unchanged in our array [74], suggesting that other pathways are involved in these observations. Components of the TGFβ signalling pathway were downregulated in PAE osteoblasts from male mice, compared to control. This is consistent with previous studies which have shown that ethanol can affect TGFβ signalling in the brain [75,76,77,78] and the articular cartilage [79]. Defects in cleft palate formation are evident in FASD models and this process requires crosstalk between the TGFβ pathway and Sonic hedgehog (Shh) [80, 81]. Interestingly, the detrimental effects of PAE can be partially remedied by increased Shh [31], adding further evidence that these may be key pathways in the underlying pathology of FASD.

We also observed downregulation of genes associated with skeletal angiogenesis (Vegfa, Vegfb and Flt1) from the PCR array, however, subsequent qPCR analysis confirmed this downregulation in PAE males during the differentiation stage of maturation (day 7), whereas the expression of Vegfa in female-derived osteoblasts was unchanged. Sexual dimorphisms in vascularisation and bone-derived VEGF signalling have previously been observed in a murine model [46]. Interestingly, bone-specific VEGF knockout altered parameters associated with cortical mass and geometry in females only, whereas despite elevations in cortical porosity in male mice, these measures were unaffected [46]. Given we did not observe alterations in VEGF expression in female-derived osteoblasts, this could explain the spatially limited effects of PAE on female bones at 12-weeks of age observed herein. However, the detrimental effects on the trabecular compartment in terms of bone mass and distribution of trabeculae observed in our skeletally mature male PAE mice contrasts with that seen in the bone-specific VEGF knockout. Furthermore, increased cortical porosity in the posterior region of the tibiofibular junction was observed in females, consistent with our previous findings [45], yet PAE females increased this further. In contrast, most interestingly, males were unaffected in this region. Evidence here suggests the complex nature of skeletal vascularisation, maintenance of bone and the sexually dimorphic actions of the genes involved, which could be affected by PAE.

Whilst we observed alterations in bone cell function and gene expression in cells derived from the calvaria, we did not examine the effects of PAE on the skull in our model. Other reports have noted craniofacial defects in murine foetuses at gestational day 17 [82, 83]. Irrespective of offspring sex, craniofacial malformations were observed equally in PAE, whereas body weight and length changes were only evident in PAE females [82]. Changes in skull size, shape variation and asymmetry have also been observed in pups at postnatal day 0, though this was not affected by sex [84]. Long-term assessment of craniofacial shape in rodent models, however, has not been performed and represents a possible avenue to further explore.

On examination of other areas of the skeleton, we observed alterations in growth plate width and number of bridges in male mice only, whilst females were unaffected. These sexually dimorphic effects of PAE on endochondral processes may therefore give rise to the detrimental effects seen on trabecular bone. Despite this, neither group appeared to have altered growth, as demonstrated by no change in tibial length or body weight. This is in contrast to evidence that growth is impaired in PAE foetuses from rat and sheep models [29, 32, 34], but supports previous evidence indicating that in this murine model of PAE, weight changes in adult (3–6 months) were no different [63]. This may in part be explained as we did not perform longitudinal body length or weight assessment during skeletal development in these mice to assess whether growth deficiencies were initially present and subsequently compensated for or it could result from species differences. Given the trend towards increased growth plate bridging, suggestive of an accelerated fusion mechanism [49], this could explain the reasons for these results. Evidence of this from human populations is limited as FASD children aged < 9 years are similar in height to age-matched controls; by adolescence, individuals with FASD are shorter [23], yet longer term studies in skeletally mature FASD adults have not been performed. In addition, previous reports identified that adult female rats, and both juvenile and adult male rats exposed to alcohol in utero were more susceptible to developing an osteoarthritis-like phenotype and display cartilage degradation [79, 85]. Although we did not observe any immediately obvious damage to the cartilage or perform investigations into osteoarthritis in this model, given the effects of PAE on the underlying subchondral bone, further investigation is necessary to elucidate whether PAE has any effect on the progression of osteoarthritis, and whether this is the case in FASD adults.

Alterations in cortical composition and geometry were observed in PAE mice of both sexes, with male PAE mice detrimentally affected along the entire tibial length. Changes to cortical bone shape can be used to predict a reduction in bone strength, as a result of failing to resist excessive strains [43, 86]. Indeed, femurs from PAE males were weaker, less stiff and could sustain less load before undergoing plastic deformation than controls. In contrast, female PAE mice only displayed alterations in bone shape in the distal tibia and displayed increased cortical porosity in the tibiofibular junction compared to controls. This therefore suggests that cortical porosity is also sex-dependent, however in an opposite manner to bone formation. Further studies investigating the interplay between sex and bone turnover markers, as well as cellular activities, in this model would allow delineation of this interaction. Whilst stiffness was unchanged, female PAE mice also showed reduced biomechanical properties (strength and yield). In a sheep model of PAE, similar reductions in tibial and femoral strength have also been observed, yet sex differences have not been reported [32, 33]. A study in FASD children has shown that they are more prone to fracture during early childhood, yet skeletal investigations in adults have not been performed [24]. Given these observations in preclinical models, further studies are warranted in human cohorts and to ensure that sex-stratification is included to delineate any potential sexual dimorphism.

Despite the profound effects of PAE at 12-weeks of age, we did not observe differences in PAE compared to control in either the males or females in our juvenile murine model (4-weeks of age), although some evidence of sex differences within the PAE group itself was evident. This therefore suggests that whilst there are inherent differences in the function and gene expression of primary osteoblasts derived from PAE neonates, the effect of PAE in vivo may require sex steroids and/or mechanical and environmental influences to exert its significant sexual dimorphic phenotype. Given that PAE leads to alterations in growth plate bridging, cortical geometry, and vascular changes at the tibiofibular junction, suggests that these changes may arise from altered responses to mechanical cues at these anatomical sites. Loading studies to assess the ability of these animals to respond to mechanical stimuli could be performed to further delineate this potential mechanism. Skeletal sex differences are observed post-puberty, demonstrating that sex steroids play a crucial role in maintaining life-long bone health [87]. Our results suggest that PAE may affect men and women differently, independent of these sex hormones. Future studies aiming to understand how PAE affects the skeleton during sex hormone depletion could reveal novel mechanisms to aid sex-stratified treatments.

Conclusions

In summary, evidence herein suggests that PAE has detrimental and sexually dimorphic effects on the skeletons of skeletally mature male and female mice. This effect is observed in spatially distinct regions of the bone and may be because of inherent differences in osteoblast function. These differences, however, were not evident in our juvenile model compared to controls and suggests a longer acting effect of PAE on the skeleton, coupled with distinct mechanoadaption between sexes when alcohol is given long term in low doses, which does not lead to immediately obvious clinical presentations. This study adds further evidence to indicate that the in-utero environment can have lasting impacts on skeletal health and that, for the first time, sex-specific changes in bone composition are evident with PAE, thus should be explored in human FASD populations to investigate this potential sexual dimorphism.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Goodfellow LR, Earl S, Cooper C, Harvey NC. Maternal diet, behaviour and offspring skeletal health. Int J Environ Res Public Health. 2010;7(4):1760–72. https://doi.org/10.3390/ijerph7041760. Epub 20100416.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Javaid MK, Cooper C. Prenatal and childhood influences on osteoporosis. Best Pract Res Clin Endocrinol Metab. 2002;16(2):349 – 67. https://doi.org/10.1053/beem.2002.0199. PubMed PMID: 12064897.

  3. Jensen KH, Riis KR, Abrahamsen B, Handel MN. Nutrients, Diet, and Other Factors in Prenatal Life and Bone Health in Young Adults: A Systematic Review of Longitudinal Studies. Nutrients. 2020;12(9). Epub 20200919. https://doi.org/10.3390/nu12092866. PubMed PMID: 32961712; PubMed Central PMCID: PMCPMC7551661.

  4. Popova S, Lange S, Shield K, Mihic A, Chudley AE, Mukherjee RAS, et al. Comorbidity of fetal alcohol spectrum disorder: a systematic review and meta-analysis. Lancet. 2016;387(10022):978–87. https://doi.org/10.1016/S0140-6736(15)01345-8. Epub 20160106.

    Article  PubMed  Google Scholar 

  5. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O’Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004;25(4):228–38. https://doi.org/10.1097/00004703-200408000-00002. PubMed PMID: 15308923.

    Article  PubMed  Google Scholar 

  6. Popova S, Charness ME, Burd L, Crawford A, Hoyme HE, Mukherjee RAS et al. Fetal alcohol spectrum disorders. Nat Rev Dis Primers. 2023;9(1):11. Epub 20230223. https://doi.org/10.1038/s41572-023-00420-x. PubMed PMID: 36823161.

  7. Lange S, Probst C, Gmel G, Rehm J, Burd L, Popova S. Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and Meta-analysis. JAMA Pediatr. 2017;171(10):948–56. PubMed PMID: 28828483; PubMed Central PMCID: PMCPMC5710622.

    Article  PubMed  PubMed Central  Google Scholar 

  8. May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D, et al. Prevalence of Fetal Alcohol Spectrum Disorders in 4 US communities. JAMA. 2018;319(5):474–82. https://doi.org/10.1001/jama.2017.21896. PubMed PMID: 29411031; PubMed Central PMCID: PMCPMC5839298.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Roozen S, Black D, Peters GY, Kok G, Townend D, Nijhuis JG, et al. Fetal Alcohol Spectrum disorders (FASD): an Approach to Effective Prevention. Curr Dev Disord Rep. 2016;3(4):229–34. https://doi.org/10.1007/s40474-016-0101-y. Epub 20161026.

    Article  PubMed  PubMed Central  Google Scholar 

  10. McQuire C, Mukherjee R, Hurt L, Higgins A, Greene G, Farewell D et al. Screening prevalence of fetal alcohol spectrum disorders in a region of the United Kingdom: A population-based birth-cohort study. Prev Med. 2019;118:344 – 51. Epub 20181130. https://doi.org/10.1016/j.ypmed.2018.10.013. PubMed PMID: 30503408; PubMed Central PMCID: PMCPMC6344226.

  11. Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(3):e290–9. https://doi.org/10.1016/S2214-109X. Epub 20170113.

    Article  PubMed  Google Scholar 

  12. Del Campo M, Jones KL. A review of the physical features of the fetal alcohol spectrum disorders. Eur J Med Genet. 2017;60(1):55–64. https://doi.org/10.1016/j.ejmg.2016.10.004. Epub 20161010.

    Article  PubMed  Google Scholar 

  13. Hoyme HE, Kalberg WO, Elliott AJ, Blankenship J, Buckley D, Marais AS et al. Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders. Pediatrics. 2016;138(2). Epub 20160727. https://doi.org/10.1542/peds.2015-4256. PubMed PMID: 27464676; PubMed Central PMCID: PMCPMC4960726.

  14. Muggli E, Matthews H, Penington A, Claes P, O’Leary C, Forster D, et al. Association between Prenatal Alcohol Exposure and Craniofacial shape of children at 12 months of age. JAMA Pediatr. 2017;171(8):771–80. https://doi.org/10.1001/jamapediatrics.2017.0778. PubMed PMID: 28586842; PubMed Central PMCID: PMCPMC6583660.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Rostand A, Kaminski M, Lelong N, Dehaene P, Delestret I, Klein-Bertrand C, et al. Alcohol use in pregnancy, craniofacial features, and fetal growth. J Epidemiol Community Health. 1990;44(4):302–6. https://doi.org/10.1136/jech.44.4.302. PubMed PMID: 2277252; PubMed Central PMCID: PMCPMC1060674.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Jaffer Z, Nelson M, Beighton P. Bone fusion in the foetal alcohol syndrome. J Bone Joint Surg Br. 1981;63B(4):569–71. https://doi.org/10.1302/0301-620X.63B4.7197678. PubMed PMID: 7197678.

    Article  CAS  PubMed  Google Scholar 

  17. Tredwell SJ, Smith DF, Macleod PJ, Wood BJ. Cervical spine anomalies in fetal alcohol syndrome. Spine (Phila Pa 1976). 1982;7(4):331–4. https://doi.org/10.1097/00007632-198207000-00002. PubMed PMID: 6890236.

    Article  CAS  PubMed  Google Scholar 

  18. Tsukahara M, Kajii T. Severe skeletal dysplasias following intrauterine exposure to ethanol. Teratology. 1988;37(1):79–81. .1420370112. PubMed PMID: 3347911.

    Article  CAS  PubMed  Google Scholar 

  19. Day NL, Leech SL, Richardson GA, Cornelius MD, Robles N, Larkby C. Prenatal alcohol exposure predicts continued deficits in offspring size at 14 years of age. Alcohol Clin Exp Res. 2002;26(10):1584–91. https://doi.org/10.1097/01.ALC.0000034036.75248.D9. PubMed PMID: 12394293.

    Article  CAS  PubMed  Google Scholar 

  20. Feldman HS, Jones KL, Lindsay S, Slymen D, Klonoff-Cohen H, Kao K et al. Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcohol Clin Exp Res. 2012;36(4):670-6. Epub 20120117. https://doi.org/10.1111/j.1530-0277.2011.01664.x. PubMed PMID: 22250768.

  21. Habbick BF, Blakley PM, Houston CS, Snyder RE, Senthilselvan A, Nanson JL. Bone age and growth in fetal alcohol syndrome. Alcohol Clin Exp Res. 1998;22(6):1312–6. PubMed PMID: 9756047.

    Article  CAS  PubMed  Google Scholar 

  22. Naidoo S, Harris A, Swanevelder S, Lombard C. Foetal alcohol syndrome: a cephalometric analysis of patients and controls. Eur J Orthod. 2006;28(3):254–61. https://doi.org/10.1093/ejo/cji110. Epub 20060428.

    Article  PubMed  Google Scholar 

  23. Young SL, Gallo LA, Brookes DSK, Hayes N, Maloney M, Liddle K, et al. Altered bone and body composition in children and adolescents with confirmed prenatal alcohol exposure. Bone. 2022;164:116510. https://doi.org/10.1016/j.bone.2022.116510. Epub 20220802.

    Article  PubMed  Google Scholar 

  24. Parviainen R, Auvinen J, Serlo W, Jarvelin MR, Sinikumpu JJ. Maternal alcohol consumption during pregnancy associates with bone fractures in early childhood. A birth-cohort study of 6718 participants. Bone. 2020;137:115462. https://doi.org/10.1016/j.bone.2020.115462. Epub 20200530.

    Article  PubMed  Google Scholar 

  25. Randall CL, Taylor J, Walker DW. Ethanol-induced malformations in mice. Alcohol Clin Exp Res. 1977;1(3):219 – 24. https://doi.org/10.1111/j.1530-0277.1977.tb05876.x. PubMed PMID: 337841.

  26. Ukita K, Fukui Y, Shiota K. Effects of prenatal alcohol exposure in mice: influence of an ADH inhibitor and a chronic inhalation study. Reprod Toxicol. 1993;7(3):273 – 81. https://doi.org/10.1016/0890-6238(93)90234-x. PubMed PMID: 8318759.

  27. Keiver K, Ellis L, Anzarut A, Weinberg J. Effect of prenatal ethanol exposure on fetal calcium metabolism. Alcohol Clin Exp Res. 1997;21(9):1612–8. PubMed PMID: 9438520.

    Article  CAS  PubMed  Google Scholar 

  28. Leichter J, Lee M. Effect of maternal ethanol administration on physical growth of the offspring in rats. Growth. 1979;43(4):288–93. PubMed PMID: 546691.

    CAS  PubMed  Google Scholar 

  29. Simpson ME, Duggal S, Keiver K. Prenatal ethanol exposure has differential effects on fetal growth and skeletal ossification. Bone. 2005;36(3):521–32. PubMed PMID: 15777686.

    Article  CAS  PubMed  Google Scholar 

  30. Keiver K, Weinberg J. Effect of duration of maternal alcohol consumption on calcium metabolism and bone in the fetal rat. Alcohol Clin Exp Res. 2004;28(3):456–67. https://doi.org/10.1097/01.alc.0000118312.38204.c5. PubMed PMID: 15084904.

    Article  CAS  PubMed  Google Scholar 

  31. Ahlgren SC, Thakur V, Bronner-Fraser M. Sonic hedgehog rescues cranial neural crest from cell death induced by ethanol exposure. Proc Natl Acad Sci U S A. 2002;99(16):10476–81. https://doi.org/10.1073/pnas.162356199. Epub 20020724.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ramadoss J, Hogan HA, Given JC, West JR, Cudd TA. Binge alcohol exposure during all three trimesters alters bone strength and growth in fetal sheep. Alcohol. 2006;38(3):185–92. https://doi.org/10.1016/j.alcohol.2006.06.004. Epub 20060726.

    Article  CAS  PubMed  Google Scholar 

  33. Sawant OB, Ramadoss J, Hogan HA, Washburn SE. The role of acidemia in maternal binge alcohol-induced alterations in fetal bone functional properties. Alcohol Clin Exp Res. 2013;37(9):1476–82. https://doi.org/10.1111/acer.12118. Epub 20130503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Snow ME, Keiver K. Prenatal ethanol exposure disrupts the histological stages of fetal bone development. Bone. 2007;41(2):181–7. https://doi.org/10.1016/j.bone.2007.04.182. Epub 20070425.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Flannigan K, Poole N, Cook J, Unsworth K. Sex-related differences among individuals assessed for fetal alcohol spectrum disorder in Canada. Alcohol Clin Exp Res (Hoboken). 2023;47(3):613–23. https://doi.org/10.1111/acer.15017. Epub 20230318.

    Article  CAS  PubMed  Google Scholar 

  36. May PA, Tabachnick B, Hasken JM, Marais AS, de Vries MM, Barnard R, et al. Who is most affected by prenatal alcohol exposure: boys or girls? Drug Alcohol Depend. 2017;177:258–67. https://doi.org/10.1016/j.drugalcdep.2017.04.010. Epub 20170615.

    Article  CAS  PubMed  Google Scholar 

  37. Weeks O, Bosse GD, Oderberg IM, Akle S, Houvras Y, Wrighton PJ, et al. Fetal alcohol spectrum disorder predisposes to metabolic abnormalities in adulthood. J Clin Invest. 2020;130(5):2252–69. https://doi.org/10.1172/JCI132139. PubMed PMID: 32202514; PubMed Central PMCID: PMCPMC7190939.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Sharma A, Michels LV, Pitsillides AA, Greeves J, Plotkin LI, Cardo V, et al. Sexing bones: improving transparency of sex reporting to address Bias within Preclinical studies. J Bone Min Res. 2023;38(1):5–13. https://doi.org/10.1002/jbmr.4729. Epub 20221113.

    Article  Google Scholar 

  39. Orriss IR, Hajjawi MO, Huesa C, MacRae VE, Arnett TR. Optimisation of the differing conditions required for bone formation in vitro by primary osteoblasts from mice and rats. Int J Mol Med. 2014;34(5):1201–8. PubMed PMID: 25200658; PubMed Central PMCID: PMCPMC4199408.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Perpetuo IP, Bourne LE, Orriss IR. Isolation and Generation of Osteoblasts. Methods Mol Biol. 2019;1914:21–38. https://doi.org/10.1007/978-1-4939-8997-3_2. PubMed PMID: 30729458.

  41. Taylor SE, Shah M, Orriss IR. Generation of rodent and human osteoblasts. Bonekey Rep. 2014;3:585. Epub 20141112. https://doi.org/10.1038/bonekey.2014.80. PubMed PMID: 25396049; PubMed Central PMCID: PMCPMC4230189.

  42. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–8. https://doi.org/10.1006/meth.2001.1262. PubMed PMID: 11846609.

    Article  CAS  PubMed  Google Scholar 

  43. Javaheri B, Razi H, Gohin S, Wylie S, Chang YM, Salmon P, et al. Lasting organ-level bone mechanoadaptation is unrelated to local strain. Sci Adv. 2020;6(10):eaax8301. https://doi.org/10.1126/sciadv.aax8301. Epub 20200306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Trend J, Sharma A, Michels L, Goggin P, Schneider P, Deinhardt K et al. Regional assessment of male murine bone exposes spatial heterogeneity in osteocyte lacunar volume associated with intracortical canals and regulation by VEGF. bioRxiv. 2023:2023.02.08.527672. https://doi.org/10.1101/2023.02.08.527672.

  45. Nunez JA, Goring A, Javaheri B, Razi H, Gomez-Nicola D, Pitsillides AA, et al. Regional diversity in the murine cortical vascular network is revealed by synchrotron X-ray tomography and is amplified with age. Eur Cell Mater. 2018;35:281–99. https://doi.org/10.22203/eCM.v035a20. Epub 20180523.

    Article  CAS  PubMed  Google Scholar 

  46. Goring A, Sharma A, Javaheri B, Smith RC, Kanczler JM, Boyde A, et al. Regulation of the bone Vascular Network is sexually dimorphic. J Bone Min Res. 2019;34(11):2117–32. https://doi.org/10.1002/jbmr.3825. Epub 20191009.

    Article  Google Scholar 

  47. Huesa C, Yadav MC, Finnila MA, Goodyear SR, Robins SP, Tanner KE, et al. PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. Bone. 2011;48(5):1066–74. https://doi.org/10.1016/j.bone.2011.01.010. Epub 20110125.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Jayash SN, Hamoudi D, Stephen LA, Argaw A, Huesa C, Joseph S, et al. Anti-RANKL therapy prevents glucocorticoid-Induced Bone loss and promotes muscle function in a mouse model of Duchenne muscular dystrophy. Calcif Tissue Int. 2023;113(4):449–68. https://doi.org/10.1007/s00223-023-01116-w. Epub 20230720.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Staines KA, Madi K, Javaheri B, Lee PD, Pitsillides AA. A computed Microtomography Method for understanding Epiphyseal Growth plate Fusion. Front Mater. 2018;4:48. https://doi.org/10.3389/fmats.2017.00048. PubMed PMID: 29417047; PubMed Central PMCID: PMCPMC5798587.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995;311(6998):171–4. https://doi.org/10.1136/bmj.311.6998.171. PubMed PMID: 7613432; PubMed Central PMCID: PMCPMC2550226.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology. 2015;40(1):61–87. https://doi.org/10.1038/npp.2014.147. Epub 20140618.

    Article  CAS  PubMed  Google Scholar 

  52. Street ME, Bernasconi S. Endocrine-disrupting chemicals in human fetal growth. Int J Mol Sci. 2020;21(4). Epub 20200220. doi: 10.3390/ijms21041430. PubMed PMID: 32093249; PubMed Central PMCID: PMCPMC7073082.

  53. Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal nutrition and fetal development. J Nutr. 2004;134(9):2169–72. https://doi.org/10.1093/jn/134.9.2169. PubMed PMID: 15333699.

    Article  CAS  PubMed  Google Scholar 

  54. Del Campo M, Kosaki K, Bennett FC, Jones KL. Developmental delay in fetal aminopterin/methotrexate syndrome. Teratology. 1999;60(1):10 – 2. doi: 10.1002/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H. PubMed PMID: 10413333.

  55. Sholts SB, Korkalainen M, Simanainen U, Miettinen HM, Hakansson H, Viluksela M. In utero/lactational and adult exposures to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) show differential effects on craniofacial development and growth in rats. Toxicology. 2015;337:30–8. PubMed PMID: 26320568.

    Article  CAS  PubMed  Google Scholar 

  56. Wangikar PB, Dwivedi P, Sharma AK, Sinha N. Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. II. Histopathological features of teratological anomalies induced in fetuses. Birth Defects Res B Dev Reprod Toxicol. 2004;71(6):352–8. https://doi.org/10.1002/bdrb.20022. PubMed PMID: 15617025.

    Article  CAS  PubMed  Google Scholar 

  57. Hoyme HE, Jones KL, Dixon SD, Jewett T, Hanson JW, Robinson LK, et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics. 1990;85(5):743–7. PubMed PMID: 2330234.

    Article  CAS  PubMed  Google Scholar 

  58. Soper JR, Bonar SF, O’Sullivan DJ, McCredie J, Willert HG. Thalidomide and neurotrophism. Skeletal Radiol. 2019;48(4):517–25. Epub 20181019. doi: 10.1007/s00256-018-3086-2. PubMed PMID: 30341712; PubMed Central PMCID: PMCPMC6394469.

    Article  PubMed  Google Scholar 

  59. Seifert MF, Church MW. Long term effects of prenatal cocaine exposure on bone in rats. Life Sci. 1991;49(8):569 – 74. https://doi.org/10.1016/0024-3205(91)90255-a. PubMed PMID: 1865751.

  60. Torchinsky A, Mizrahi L, Savion S, Shahar R, Toder V, Kobyliansky E. Bone loss in adult offspring induced by low-dose exposure to teratogens. J Bone Min Metab. 2012;30(3):270–80. https://doi.org/10.1007/s00774-011-0311-7. Epub 20110930.

    Article  CAS  Google Scholar 

  61. Schölin L, Mukherjee RAS, Aiton N, Blackburn C, Brown S, Flemming KM, et al. Fetal alcohol spectrum disorders: an overview of current evidence and activities in the UK. Arch Dis Child. 2021;106(7):636–40. https://doi.org/10.1136/archdischild-2020-320435. PubMed PMID: WOS:000667720200010.

    Article  PubMed  Google Scholar 

  62. Petrelli B, Weinberg J, Hicks GG. Effects of prenatal alcohol exposure (PAE): insights into FASD using mouse models of PAE. Biochem Cell Biol. 2018;96(2):131–47. https://doi.org/10.1139/bcb-2017-0280. PubMed PMID: WOS:000429897700008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Fidalgo S, Skipper C, Takyi A, McIver A, Tsiligkaridis T, Quadir A, et al. Low-dose chronic prenatal alcohol exposure abolishes the pro-cognitive effects of angiotensin IV. Behav Brain Res. 2017;329:140–7. https://doi.org/10.1016/j.bbr.2017.04.042. Epub 20170427.

    Article  CAS  PubMed  Google Scholar 

  64. Treit S, Chen Z, Zhou D, Baugh L, Rasmussen C, Andrew G, et al. Sexual dimorphism of volume reduction but not cognitive deficit in fetal alcohol spectrum disorders: a combined diffusion tensor imaging, cortical thickness and brain volume study. Neuroimage Clin. 2017;15:284–97. https://doi.org/10.1016/j.nicl.2017.05.006. Epub 20170510.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Liu L, Wen Y, Ni Q, Chen L, Wang H. Prenatal ethanol exposure and changes in fetal neuroendocrine metabolic programming. Biol Res. 2023;56(1):61. https://doi.org/10.1186/s40659-023-00473-y. Epub 20231117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, et al. Cytokines and alcohol. Alcohol Clin Exp Res. 2006;30(4):720–30. https://doi.org/10.1111/j.1530-0277.2006.00084. .x. PubMed PMID: 16573591.

    Article  CAS  PubMed  Google Scholar 

  67. Bodnar TS, Raineki C, Wertelecki W, Yevtushok L, Plotka L, Zymak-Zakutnya N et al. Altered maternal immune networks are associated with adverse child neurodevelopment: Impact of alcohol consumption during pregnancy. Brain Behav Immun. 2018;73:205 – 15. Epub 20180505. https://doi.org/10.1016/j.bbi.2018.05.004. PubMed PMID: 29738852; PubMed Central PMCID: PMCPMC6344127.

  68. Enninga EA, Nevala WK, Creedon DJ, Markovic SN, Holtan SG. Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. Am J Reprod Immunol. 2015;73(3):251–62. https://doi.org/10.1111/aji.12303. Epub 20140804.

    Article  CAS  PubMed  Google Scholar 

  69. Gardiner AS, Gutierrez HL, Luo L, Davies S, Savage DD, Bakhireva LN, et al. Alcohol use during pregnancy is Associated with specific alterations in MicroRNA levels in maternal serum. Alcohol Clin Exp Res. 2016;40(4):826–37. https://doi.org/10.1111/acer.13026. PubMed PMID: 27038596; PubMed Central PMCID: PMCPMC4825401.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Ruffaner-Hanson C, Noor S, Sun MS, Solomon E, Marquez LE, Rodriguez DE, et al. The maternal-placental-fetal interface: adaptations of the HPA axis and immune mediators following maternal stress and prenatal alcohol exposure. Exp Neurol. 2022;355:114121. https://doi.org/10.1016/j.expneurol.2022.114121. Epub 20220520.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Bake S, Rouzer SK, Mavuri S, Miranda RC, Mahnke AH. The interaction of genetic sex and prenatal alcohol exposure on health across the lifespan. Front Neuroendocrin. 2023;71. ARTN 101103. https://doi.org/10.1016/j.yfrne.2023.101103. PubMed PMID: WOS:001098647200001.

  72. Brylka L, Jahnen-Dechent W. The role of fetuin-A in physiological and pathological mineralization. Calcif Tissue Int. 2013;93(4):355–64. https://doi.org/10.1007/s00223-012-9690-6. Epub 20130101.

    Article  CAS  PubMed  Google Scholar 

  73. Mattinzoli D, Rastaldi MP, Ikehata M, Armelloni S, Pignatari C, Giardino LA, et al. FGF23-regulated production of Fetuin-A (AHSG) in osteocytes. Bone. 2016;83:35–47. https://doi.org/10.1016/j.bone.2015.10.008. Epub 20151023.

    Article  CAS  PubMed  Google Scholar 

  74. Bourne LE, Wheeler-Jones CP, Orriss IR. Regulation of mineralisation in bone and vascular tissue: a comparative review. J Endocrinol. 2021;248(2):R51–65. https://doi.org/10.1530/JOE-20-0428. PubMed PMID: 33337345.

    Article  CAS  PubMed  Google Scholar 

  75. Kuhn P, Sarkar DK. Ethanol induces apoptotic death of beta-endorphin neurons in the rat hypothalamus by a TGF-beta 1-dependent mechanism. Alcohol Clin Exp Res. 2008;32(4):706 – 14. Epub 20080313. https://doi.org/10.1111/j.1530-0277.2008.00627.x. PubMed PMID: 18341643.

  76. Powrozek TA, Miller MW. Ethanol affects transforming growth factor beta1-initiated signals: cross-talking pathways in the developing rat cerebral wall. J Neurosci. 2009;29(30):9521–33. https://doi.org/10.1523/JNEUROSCI.2371-09.2009. PubMed PMID: 19641115; PubMed Central PMCID: PMCPMC6666549.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Siegenthaler JA, Miller MW. Transforming growth factor beta 1 promotes cell cycle exit through the cyclin-dependent kinase inhibitor p21 in the developing cerebral cortex. J Neurosci. 2005;25(38):8627–36. https://doi.org/10.1523/JNEUROSCI.1876-05.2005. PubMed PMID: 16177030; PubMed Central PMCID: PMCPMC6725510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Siegenthaler JA, Miller MW. Ethanol disrupts cell cycle regulation in developing rat cortex interaction with transforming growth factor beta1. J Neurochem. 2005;95(3):902–12. https://doi.org/10.1111/j.1471-4159.2005.03461. Epub 20050929.

    Article  CAS  PubMed  Google Scholar 

  79. Ni Q, Tan Y, Zhang X, Luo H, Deng Y, Magdalou J, et al. Prenatal ethanol exposure increases osteoarthritis susceptibility in female rat offspring by programming a low-functioning IGF-1 signaling pathway. Sci Rep. 2015;5:14711. https://doi.org/10.1038/srep14711. Epub 20151005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Ohki S, Oka K, Ogata K, Okuhara S, Rikitake M, Toda-Nakamura M, et al. Transforming growth factor-Beta and sonic hedgehog signaling in Palatal Epithelium regulate Tenascin-C expression in Palatal Mesenchyme during Soft Palate Development. Front Physiol. 2020;11:532. https://doi.org/10.3389/fphys.2020.00532. Epub 20200604.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Sasaki Y, O’Kane S, Dixon J, Dixon MJ, Ferguson MW. Temporal and spatial expression of Pax9 and sonic hedgehog during development of normal mouse palates and cleft palates in TGF-beta3 null embryos. Arch Oral Biol. 2007;52(3):260–7. https://doi.org/10.1016/j.archoralbio.2006.09.012. Epub 20061113.

    Article  CAS  PubMed  Google Scholar 

  82. Boschen KE, Gong H, Murdaugh LB, Parnell SE. Knockdown of Mns1 increases susceptibility to Craniofacial defects following gastrulation-stage alcohol exposure in mice. Alcohol Clin Exp Res. 2018;42(11):2136–43. https://doi.org/10.1111/acer.13876. Epub 20180910.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Anthony B, Vinci-Booher S, Wetherill L, Ward R, Goodlett C, Zhou FC. Alcohol-induced facial dysmorphology in C57BL/6 mouse models of fetal alcohol spectrum disorder. Alcohol. 2010;44(7–8):659–71. PubMed PMID: WOS:000285274000011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Draghici D, Barr K, Hardy DB, Allman BL, Willmore KE. Effects of advanced maternal age and acute prenatal alcohol exposure on mouse offspring growth and craniofacial phenotype. Alcohol Clin Exp Res. 2021;45(7):1383–97. https://doi.org/10.1111/acer.14631. Epub 20210604.

    Article  CAS  PubMed  Google Scholar 

  85. Ni QB, Lu KH, Li J, Tan Y, Qin J, Magdalou J, et al. Role of TGFβ signaling in maternal ethanol-Induced fetal articular cartilage dysplasia and adult onset of Osteoarthritis in male rats. Toxicol Sci. 2018;164(1):179–90. https://doi.org/10.1093/toxsci/kfy080. PubMed PMID: WOS:000503280700001.

    Article  CAS  PubMed  Google Scholar 

  86. Bertram JE, Biewener AA. Bone curvature: sacrificing strength for load predictability? J Theor Biol. 1988;131(1):75–92. https://doi.org/10.1016/s0022-5193(88)80122-x. PubMed PMID: 3419194.

  87. Khosla S, Monroe DG. Regulation of Bone Metabolism by Sex Steroids. Csh Perspect Med. 2018;8(1). doi: ARTN a03121110.1101/cshperspect.a031211. PubMed PMID: WOS:000429143200009.

Download references

Acknowledgements

The authors would like to thank the Bioresources Unit at the University of Brighton for the assistance with the care of animal models in this study. We are also thankful to Dr Ruby Chang (Royal Veterinary College, UK) for her discussions regarding the statistical analysis.

Funding

The authors would like to acknowledge the UK Medical Research Council (MRC) for funding to KAS (MR/V033506/1 & MR/R022240/2) and the Biotechnology and Biological Sciences Research Council (BBSRC) for Institute Strategic Programme Grant Funding BBS/E/D/10002071 and BBS/E/RL/230001C (SNJ).

Author information

Authors and Affiliations

  1. School of Applied Sciences, Centre for Lifelong Health, University of Brighton, Lewes Road, Brighton, BN2 4GT, UK

    Lucie E. Bourne, Paul Gard, Nigel Brissett & Katherine A. Staines

  2. The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK

    Soher N. Jayash

  3. School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK

    Lysanne V. Michels & Claire E. Clarkin

  4. Comparative Biomedical Sciences, Royal Veterinary College, London, NW1 0TU, UK

    Mark Hopkinson

  5. Institute of Life and Earth Sciences, School of Energy, Geosciences, Infrastructure and Society, Heriot Watt University, Edinburgh, EH14 4AS, UK

    Fergus M. Guppy

Authors
  1. Lucie E. Bourne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soher N. Jayash
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lysanne V. Michels
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark Hopkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fergus M. Guppy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claire E. Clarkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Paul Gard
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nigel Brissett
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Katherine A. Staines
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study design: LEB, FMG, PG, NB, KAS; Analysis and interpretation of the data; all authors; Drafting the manuscript: LEB, KAS; Editing and approving final version: all authors.

Corresponding author

Correspondence to Katherine A. Staines.

Ethics declarations

Ethics approval and consent to participate

All experimental procedures were performed in accordance with the UK Animals (Scientific Procedures) Act of 1986 and regulations set by the UK Home Office and local institutional guidelines.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bourne, L.E., Jayash, S.N., Michels, L.V. et al. Sexually dimorphic effects of prenatal alcohol exposure on the murine skeleton. Biol Sex Differ 15, 51 (2024). https://doi.org/10.1186/s13293-024-00626-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13293-024-00626-y

Keywords

Biology of Sex Differences

ISSN: 2042-6410

Contact us